Clinical Trial Update: O6-Benzylguanine and Temozolomide in Treating Young Patients With Recurrent or Progressive Gliomas or Brain Stem Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating O6-Benzylguanine with Temozolomide in young patients with recurrent or progressive gliomas or brain stem tumors has completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Stem Tumor
• Brain Tumors
• Glioma

Drugs mentioned

• O6-Benzylguanine (O6-Benzylguanine)
• Temozolomide (Temozolomide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED | Results posted: 2011-08-09